These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3959487)

  • 1. [The intermediate form of maple syrup disease].
    Rittinger O; Bachmann C; Irnberger T; Pilz P; Walter GF; Wendel U; Plöchl E
    Klin Padiatr; 1986; 198(1):37-43. PubMed ID: 3959487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiamine response in maple syrup urine disease.
    Fernhoff PM; Lubitz D; Danner DJ; Dembure PP; Schwartz HP; Hillman R; Bier DM; Elsas LJ
    Pediatr Res; 1985 Oct; 19(10):1011-6. PubMed ID: 3903643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent neurological symptoms in a girl with a maple syrup urine disease (MSUD) variant.
    Holmgren G; Brundin A; Gustavson KH; Sjögren S; Kleijer WJ; Niermeijer MF
    Neuropediatrics; 1980 Nov; 11(4):377-83. PubMed ID: 7207707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermediate maple syrup urine disease: neuroimaging observations in 3 patients from South India.
    Bindu PS; Shehanaz KE; Christopher R; Pal PK; Ravishankar S
    J Child Neurol; 2007 Jul; 22(7):911-3. PubMed ID: 17715290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maple syrup urine disease: case report of 2 Thai infants.
    Chiemchanya S; Suthutvoravut U; Visudhiphan P
    J Med Assoc Thai; 1989 Jan; 72 Suppl 1():116-20. PubMed ID: 2732631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma amino acid analyses in two cases of maple syrup urine disease.
    Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild variant of maple syrup urine disease.
    Kovács J; Kiss P
    Acta Paediatr Acad Sci Hung; 1978; 19(2):137-43. PubMed ID: 707084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Branched-chain amino acid-free parenteral nutrition in the treatment of acute metabolic decompensation in patients with maple syrup urine disease.
    Berry GT; Heidenreich R; Kaplan P; Levine F; Mazur A; Palmieri MJ; Yudkoff M; Segal S
    N Engl J Med; 1991 Jan; 324(3):175-9. PubMed ID: 1898534
    [No Abstract]   [Full Text] [Related]  

  • 9. Variant maple syrup urine disease in mother and daughter.
    Zaleski LA; Dancis J; Cox RP; Hutzler J; Zaleski WA; Hill A
    Can Med Assoc J; 1973 Aug; 109(4):299-300 passim. PubMed ID: 4730202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3 patients with maple syrup urine disease].
    Merinero B; del Valle JA; García MJ; García Miguel MJ; Barrio MI; García Hortelano J; Morales E; González F; García Aparicio J; Sáez Pérez E
    An Esp Pediatr; 1983 Nov; 19(5):393-400. PubMed ID: 6660657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease.
    Schönberger S; Schweiger B; Schwahn B; Schwarz M; Wendel U
    Mol Genet Metab; 2004 May; 82(1):69-75. PubMed ID: 15110325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute encephalopathy due to late-onset maple syrup urine disease in a school boy].
    Qu SQ; Yang LC; Luan Z; Du K; Yang H
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Mar; 14(3):161-4. PubMed ID: 22433398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intermittent maple syrup urine disease in a 12-year-old boy: clinical aspects, diagnosis and treatment].
    Fritsch G; Langenbeck U; Wendel U; Lehnert W; Palm W; Steger W
    Klin Padiatr; 1983; 195(5):351-4. PubMed ID: 6632715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal protein and lipid compositions of the cerebral myelin of a patient with maple syrup urine disease.
    Taketomi T; Kunishita T; Hara A; Mizushima S
    Jpn J Exp Med; 1983 Apr; 53(2):109-16. PubMed ID: 6663802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Branched-chain alpha-keto acids for the diagnosis of maple-syrup-urine disease.
    Parsons H; Fung E; Snyder FF
    N Engl J Med; 1987 Apr; 316(15):951. PubMed ID: 3821846
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of maple syrup urine disease on resin coated chromatosheets.
    Kovács J
    Acta Biochim Biophys Acad Sci Hung; 1979; 14(3):119-21. PubMed ID: 547666
    [No Abstract]   [Full Text] [Related]  

  • 17. Nasogastric drip feeding as the only treatment of neonatal maple syrup urine disease.
    Parini R; Sereni LP; Bagozzi DC; Corbetta C; Rabier D; Narcy C; Hubert P; Saudubray JM
    Pediatrics; 1993 Aug; 92(2):280-3. PubMed ID: 8337030
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular and biochemical basis of intermediate maple syrup urine disease. Occurrence of homozygous G245R and F364C mutations at the E1 alpha locus of Hispanic-Mexican patients.
    Chuang JL; Davie JR; Chinsky JM; Wynn RM; Cox RP; Chuang DT
    J Clin Invest; 1995 Mar; 95(3):954-63. PubMed ID: 7883996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mid-term outcome of 2 cases with maple syrup urine disease: role of liver transplantation in the treatment].
    Netter JC; Cossarizza G; Narcy C; Hubert P; Ogier H; Revillon Y; Rabier D; Saudubray JM
    Arch Pediatr; 1994 Aug; 1(8):730-4. PubMed ID: 7842107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maple syrup urine disease in a Bedouin tribe: pre- and postnatal diagnosis.
    Potashnik R; Carmi R; Sofer S; Bashan N; Abeliovich D
    Isr J Med Sci; 1987 Aug; 23(8):886-9. PubMed ID: 3679791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.